Minerva Neurosciences, Inc. (NERV) stock
NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.30−0.08 (-3.36%)
Close on Nov 13, 2026Market cap $109.82MP/E –Yield –
Minerva Neurosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Minerva Neurosciences's enterprise value was $45.63M on Nov 11, 2026, against $16.95M a year earlier. Over the last 5 years it ranged from -$40.63M to $203.31M, with a median of -$9.47M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $45.63M | +188.3% |
| 2025 | Dec 31, 2025 | $15.83M | – |
| 2024 | Dec 31, 2024 | -$10.99M | – |
| 2023 | Dec 29, 2023 | -$3.89M | – |
| 2022 | Dec 30, 2022 | -$31.73M | – |
| 2021 | Dec 31, 2021 | -$31.37M | -146.6% |
| 2020 | Dec 31, 2020 | $67.34M | -69.0% |
| 2019 | Dec 31, 2019 | $217.54M | +32.5% |
| 2018 | Dec 31, 2018 | $164.22M | +62.3% |
| 2017 | Dec 29, 2017 | $101.21M | -68.6% |
| 2016 | Dec 30, 2016 | $322.18M | +163.7% |
| 2015 | Dec 31, 2015 | $122.18M | +39.8% |
| 2014 | Dec 31, 2014 | $87.37M | – |
See a number that looks wrong?